Find the latest Johnson & Johnson Common Stock (JNJ) annual income statements, balance sheets, financial statements, ratios, and cash flow data at Nasdaq.com.
The newJohnson & Johnsonwould remain committed to changing the trajectory of human health. The Pharmaceutical and Medical Devices segments, which are expected to generate revenue of approximately $77 billion in Full-Year 2021[1], are united by t...
Get the detailed income statement for Johnson & Johnson (JNJ). Up to 10 years of financial statements. Quarterly or annual. View as % YoY growth or as % of revenue.
Revenue (2022)$85.2B6.5%(2022 vs 2021) EPSXYZ Net Income (2022)XYZ95.9%(2022 vs 2021) Market Cap*$402.0B Net Profit Margin (2022)XYZ84.0%(2022 vs 2021) * As ofand is in US$ View Johnson & Johnson financials Johnson & Johnson premium industry data and analytics ...
Good morning, and welcome to Johnson & Johnson’s Second Quarter 2021 Earnings Conference Call. [Operator Instructions] The call is being recorded. [Operator Instructions] I would now like to turn the conference call over to Johnson & Johnson. You may begin. ...
Johnson & Johnson, normally a defensive stock, has fallen more than the S&P 500 during this downturn.
Headquarters: 1 Johnson And Johnson Plaza, New Brunswick, NJ 08901 Website: http://www.jjmt.com.tw/ Employees: 130000 Johnson & Johnson - Operating Industries and Main Competitors pie_chart OD4125 - Acne Treatment Manufacturing OTC Johnson & Johnson Market Share: x.x%lock Reckitt Benckiser Gr...
2021 2022 2023 2024 (projected) Gross Profit 55.3B 55.4B 58.4B 34.3B Total Revenue 78.7B 80.0B 85.2B 49.3B Gross ProfitTotal RevenueJohnson Johnson income statement Correlations Depreciation And Amortization Interest Expense Total Revenue Gross Profit Other Operating Expenses Operating Income Ebit Ebitd...
The Company is also working to advance research and development for the next generation of TB drugs and regimens, both in our own labs and as a member of the PAN-TB and UNITE4TB collaborations and the AMR Action Fund. Additionally, in July 20...
Sales of $21.1 billion reflecting an overall and operational increase of 1.7%*, and adjusted operational increase of 2.0%* despite the estimated negative impact of the COVID-19 pandemic